AcelRx Pharmaceuticals Inc (ACRX)

3.23
0.03 0.78
NASDAQ : Health Care
Prev Close 3.20
Open 3.25
Day Low/High 3.20 / 3.25
52 Wk Low/High 2.40 / 5.88
Volume 340.15K
Avg Volume 1.29M
Exchange NASDAQ
Shares Outstanding 45.38M
Market Cap 145.22M
EPS -0.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Stocks Under $10 Weekly Summary

We remain cautious during this historically volatile month for the market.

Stocks Under $10 Weekly Summary

We scaled into one position during a week dominated by Hurricane Harvey and its aftermath.

Stocks Under $10 Weekly Summary

We initiated 2 small positions last week as the market moved higher.

Stocks Under $10 Weekly Summary

We used last week's weakness to scale into several positions.

Stocks Under $10 Weekly Summary

North Korea puts a worrying wrinkle in the markets. We add to 2 portfolio positions.

Stocks Under $10 Weekly Summary

It was a rough week for the portfolio.

Stick With AcelRx Pharmaceuticals Despite Selloff

Unless there is a dilution event around the corner, the selloff is overdone.

Adding to 2 Positions

We'll purchase more shares of Pixelworks and Inovio ahead of their quarterly results next week.

AcelRx Pharmaceuticals Reports Successful Outcome Of ZALVISO Phase 3 IAP312 Study On Device Functionality

AcelRx Pharmaceuticals Reports Successful Outcome Of ZALVISO Phase 3 IAP312 Study On Device Functionality

- Study Objective Achieved with 2.2% of Patients Experiencing a Device Error -

Stocks Under $10 Weekly Summary

We made several trades and price target changes during a mixed week for the portfolio.

Raising Our Price Target on 2 Holdings, Cutting It on One

Sometimes, changing the price target is better than selling (or buying).

Stocks Under $10 Weekly Summary

The portfolio has some high fliers and underperformers last week as we head into the heart of earnings season.

Interesting ACRX Call Options For March 2018

Investors in AcelRx Pharmaceuticals Inc saw new options begin trading today, for the March 2018 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 235 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Adding to a Name on Weakness

It's hard to ignore INO's price this far below our cost basis.

A Pharma Pairs Trade

We'll take some profits in AcelRx and lower our cost basis on Inovio.

Stocks Under $10 Weekly Summary

We brought a new name into the portfolio last week as the Fed's comments helped lift the market.

Adding to a Biotech Position

We'll lower our cost basis on Inovio Pharmaceuticals.

Stocks Under $10 Weekly Summary

We made no trades during the holiday-shortened week, but added to our natural hedge today.

Stocks Under $10 Weekly Summary

We added a name to the portfolio's Bullpen as a whirlwind quarter came to an end.

Stocks Under $10 Weekly Summary

We exited 2 positions and took some profits during a busy week for the portfolio.

Stocks Under $10 Weekly Summary

We initiated a new position and made several other trades during a week of twists and turns.

Stocks Under $10 Weekly Summary

We initiated 2 new positions in a week dominated by political events.

Adding to AcelRx on Weakness

Shares have dropped to the level we mentioned Friday.

Initiating Position in Biotech; Update on ACRX

We're buying a small position in Inovio Pharmaceuticals and downgrading AcelRx.

TheStreet Quant Rating: D- (Sell)